Curcumin and omega-3 fatty acids enhance NK cell-induced apoptosis of pancreatic cancer cells but curcumin Inhibits Interferon-γ production: Benefits of omega-3 with curcumin against cancer

Molecules

Volumn 20, Issue 2, 2015, Pages 3020-3026

  Fiala, Milan ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Curcuminoids; Natural killer cells; Omega 3 fatty acids; Pancreatic cancer

Indexed keywords

CURCUMIN; GAMMA INTERFERON; IFNG PROTEIN, HUMAN; IL6 PROTEIN, HUMAN; INTERLEUKIN 6; OMEGA 3 FATTY ACID; STAT1 PROTEIN; STAT1 PROTEIN, HUMAN; STAT3 PROTEIN; STAT3 PROTEIN, HUMAN; TUMOR PROTEIN;

ANIMAL; HUMAN; IMMUNOLOGY; NATURAL KILLER CELL; PANCREATIC NEOPLASMS; PATHOLOGY;

ANIMALS; CURCUMIN; FATTY ACIDS, OMEGA-3; HUMANS; INTERFERON-GAMMA; INTERLEUKIN-6; KILLER CELLS, NATURAL; NEOPLASM PROTEINS; PANCREATIC NEOPLASMS; STAT1 TRANSCRIPTION FACTOR; STAT3 TRANSCRIPTION FACTOR;

EID: 84928633824     PISSN: None     EISSN: 14203049     Source Type: Journal    
DOI: 10.3390/molecules20023020     Document Type: Review

References (32)

1. Halder, R.; Almasi, A.; Sagong, B.; Leung, J.; Jewett, A.; Fiala, M. Curcumin and ω-3 fatty acids potentiate cytotoxicity of natural killer cells against pancreatic ductal adenocarcinoma cells and inhibit interferon γ production. Front. Physiol. 2015, submitted.
2. Aggarwal, S.; Ichikawa, H.; Takada, Y.; Sandur, S.K.; Shishodia, S.; Aggarwal, B.B. Curcumin (diferuloylmethane) down-regulates expression of cell proliferation and antiapoptotic and metastatic gene products through suppression of IkappaBalpha kinase and Akt activation. Mol. Pharmacol. 2006, 69, 195-206.
3. Baud, V.; Karin, M. Is NF-kappaB a good target for cancer therapy? Hopes and pitfalls. Nat. Rev. Drug Discov. 2009, 8, 33-40.
4. Kim, K.; Ryu, K.; Ko, Y.; Park, C. Effects of nuclear factor-κB inhibitors and its implication on natural killer T-cell lymphoma cells. Br. J. Haematol. 2005, 131, 59-66.
5. Siddiqui, R.A.; Harvey, K.A.; Walker, C.; Altenburg, J.; Xu, Z.; Terry, C.; Camarillo, I.; Jones-Hall, Y.; Mariash, C. Characterization of synergistic anti-cancer effects of docosahexaenoic acid and curcumin on DMBA-induced mammary tumorigenesis in mice. BMC Cancer 2013, 13, 418.
6. Swamy, M.V.; Citineni, B.; Patlolla, J.M.R.; Mohammed, A.; Zhang, Y.; Rao, C.V. Prevention and treatment of pancreatic cancer by curcumin in combination with omega-3 fatty acids. Nutr. Cancer 2008, 60, 81-89.
7. Sideras, K.; Braat, H.; Kwekkeboom, J.; van Eijck, C.H.; Peppelebosch, M.P.; Sleijfer, S.; Bruno, M. Role of the immune system in pancreatic cancer progression and immune modulating treatment strategies. Cancer Treat Rev. 2014, 40, 513-522.
8. Yu, H.; Kortylewski, M.; Pardoll, D. Crosstalk between cancer and immune cells: Role of STAT3 in the tumour microenvironment. Nat. Rev. Immunol. 2007, 7, 41-51.
9. Wang, T.; Niu, G.; Kortylewski, M.; Burdelya, L.; Shain, K.; Zhang, S.; Bhattacharya, R.; Gabrilovich, D.; Heller, R.; Coppola, D.; et al. Regulation of the innate and adaptive immune responses by Stat-3 signaling in tumor cells. Nat. Med. 2004, 10, 48-54.
10. Kim, H.Y.; Park, E.J.; Joe, E.-H.; Jou, I. Curcumin suppresses Janus kinase-STAT inflammatory signaling through activation of Src homology 2 domain-containing tyrosine phosphatase 2 in brain microglia. J. Immunol. 2003, 171, 6072-6079.
11. Bill, M.A.; Bakan, C.; Benson, D.M., Jr.; Fuchs, J.; Young, G.; Lesinski, G.B. Curcumin induces proapoptotic effects against human melanoma cells and modulates the cellular response to immunotherapeutic cytokines. Mol. Cancer Ther. 2009, 8, 2726-2735.
12. Imada, K.; Bloom, E.T.; Nakajima, H.; Horvath-Arcidiacono, J.A.; Udy, G.B.; Davey, H.W.; Leonard, W.J. Stat5b is essential for natural killer cell-mediated proliferation and cytolytic activity. J. Exp. Med. 1998, 188, 2067-2074.
13. Kanai, M.; Yoshimura, K.; Asada, M.; Imaizumi, A.; Suzuki, C.; Matsumoto, S.; Nishimura, T.; Mori, Y.; Masui, T.; Kawaguchi, Y.; et al. A phase I/II study of gemcitabine-based chemotherapy plus curcumin for patients with gemcitabine-resistant pancreatic cancer. Cancer Chemother. Pharmacol. 2011, 68, 157-164.
14. Varalakshmi, C.; Mubarak Ali, A.; Pardhasaradhi, B.V.V.; Srivastava, R.M.; Singh, S.; Khar, A. Immunomodulatory effects of curcumin: In-vivo. Int. Immunopharmacol. 2008, 8, 688-700.
15. Song, M.Y.; Yim, J.Y.; Yim, J.M.; Kang, I.J.; Rho, H.W.; Kim, H.S.; Yhim, H.Y.; Lee, N.R.; Song, E.K.; Kwak, J.Y.; et al. Use of curcumin to decrease nitric oxide production during the induction of antitumor responses by IL-2. J. Immunother. 2011, 34, 149-164.
16. Bimonte, S.; Barbieri, A.; Palma, G.; Luciano, A.; Rea, D.; Arra, C. Curcumin inhibits tumor growth and angiogenesis in an orthotopic mouse model of human pancreatic cancer. BioMed Res. Int. 2013, 2013, 810423.
17. Dhillon, N.; Aggarwal, B.B.; Newman, R.A.; Wolff, R.A.; Kunnumakkara, A.B.; Abbruzzese, J.L.; Ng, C.S. Phase II trial of curcumin in patients with advanced pancreatic cancer. Clin. Cancer Res. 2008, 14, 4491-4499.
18. Goel, A.; Aggarwal, B.B. Curcumin, the golden spice from Indian saffron, is a chemosensitizer and radiosensitizer for tumors and chemoprotector and radioprotector for normal organs. Nutr. Cancer 2010, 62, 919-930.
19. Zhou, D.Y.; Zhang, K.; Conney, A.H.; Ding, N.; Cui, X.X.; Wang, H.; Verano, M.; Zhao, S.Q.; Fan, Y.X.; Zheng, X.; et al. Synthesis and evaluation of curcumin-related compounds containing benzyl piperidone for their effects on human cancer cells. Chem. Pharm. Bull. 2013, 61, 1149-1155.
20. Dandawate, P.R.; Vyas, A.; Ahmad, A.; Banerjee, S.; Deshpande, J.; Venkateswara Swamy, K.; Jamadar, A.; Dumhe-Klaire, A.C.; Padhye, S.; Sarkar, F.H. Inclusion complex of novel curcumin analogue CDF and β-cyclodextrin (1:2) and its enhanced in vivo anticancer activity against pancreatic cancer. Pharm. Res. 2012, 29, 1775-1786.
21. Wei, X.; Du, Z.-Y.; Zheng, X.; Cui, X.-X.; Conney, A.H.; Zhang, K. Synthesis and evaluation of curcumin-related compounds for anticancer activity. Eur. J. Med. Chem. 2012, 53, 235-245.
22. Padhye, S.; Chavan, D.; Pandey, S.; Deshpande, J.; Swamy, K.V.; Sarkar, F.H. Perspectives on chemopreventive and therapeutic potential of curcumin analogs in medicinal chemistry. Mini. Rev. Med. Chem. 2010, 10, 372-387.
23. Wang, W.; Edington, H.D.; Rao, U.N.; Jukic, D.M.; Land, S.R.; Ferrone, S.; Kirkwood, J.M. Modulation of signal transducers and activators of transcription 1 and 3 signaling in melanoma by high-dose IFNalpha2b. Clin. Cancer Res. 2007, 13, 1523-1531.
24. Bill, M.A.; Fuchs, J.R.; Li, C.; Yui, J.; Bakan, C.; Benson, D.M.; Schwartz, E.B.; Abdelhamid, D.; Lin, J.; Hoyt, D.G.; et al. The small molecule curcumin analog FLLL32 induces apoptosis in melanoma cells via STAT3 inhibition and retains the cellular response to cytokines with anti-tumor activity. Mol. Cancer 2010, 9, 165.
25. Buckley, C.D.; Gilroy, D.W.; Serhan, C.N. Proresolving lipid mediators and mechanisms in the resolution of acute inflammation. Immunity 2014, 40, 315-327.
26. Xia, S.; Lu, Y.; Wang, J.; He, C.; Hong, S.; Serhan, C.N.; Kang, J.X. Melanoma growth is reduced in fat-1 transgenic mice: impact of omega-6/omega-3 essential fatty acids. Proc. Natl. Acad. Sci. USA 2006, 103, 12499-12504.
27. Greene, E.R.; Huang, S.; Serhan, C.N.; Panigrahy, D. Regulation of inflammation in cancer by eicosanoids. Prostaglandins Other Lipid Mediat. 2011, 96, 27-36.
28. Serhan, C.N.; Petasis, N.A. Resolvins and protectins in inflammation resolution. Chem. Rev. 2011, 111, 5922-5943.
29. Lai, P.; Rabinowich, H.; Crowley-Nowick, P.A.; Bell, M.C.; Mantovani, G.; Whiteside, T.L. Alterations in expression and function of signal-transducing proteins in tumor-associated T and natural killer cells in patients with ovarian carcinoma. Clin. Cancer Res. 1996, 2, 161-173.
30. Vivier, E.; Raulet, D.H.; Moretta, A.; Caligiuri, M.A.; Zitvogel, L.; Lanier, L.L.; Yokoyama, W.M.; Ugolini, S. Innate or adaptive immunity? The example of natural killer cells. Science 2011, 331, 44-49.
31. Zaidi, M.R.; Merlino, G. The two faces of interferon-gamma in cancer. Clin. Cancer Res. 2011, 17, 6118-6124.
32. Serhan, C.N.; Dalli, J.; Colas, R.A.; Winkler, J.W.; Chiang, N. Protectins and maresins: New pro-resolving families of mediators in acute inflammation and resolution bioactive metabolome. Biochim. Biophys. Acta 2014, 1851, 397-413.